Literature DB >> 8460602

Food preferences, body weight, and platelet-poor plasma serotonin and catecholamines.

I Blum1, L Nessiel, E Graff, A Harsat, U Gabbay, J Sulkes, O Raz, Y Vered.   

Abstract

The possible relationship between body weight, food preferences, and plasma neurotransmitters was investigated in 96 healthy volunteers. The volunteers were divided into groups according to sex, body mass index, and food preferences. In all groups fasting platelet-poor plasma (PPP) norepinephrine and serotonin (5-HT) were examined. PPP-5-HT was low in obese individuals (mean +/- SD: 51.7 +/- 34.6 nmol/L) in comparison with lean individuals (94.31 +/- 85.2 nmol/L; P < 0.01), in lean male carbohydrate cravers (22.7 +/- 16.4 nmol/L) in comparison with protein cravers (132.9 +/- 80.6 nmol/L; P < 0.005) and noncravers (64.7 +/- 51.7 nmol/L; P < 0.05), and in obese male carbohydrate cravers (34 +/- 22.7 nmol/L) in comparison with obese male protein cravers (98.8 +/- 28.4 nmol/L; P < 0.001). In conclusion, PPP-5-HT might be seen as a peripheral indicator of processes linked with food consumption and food preferences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460602     DOI: 10.1093/ajcn/57.4.486

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  2 in total

1.  Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults.

Authors:  P A Velasquez-Mieyer; P A Cowan; K L Arheart; C K Buffington; K A Spencer; B E Connelly; G W Cowan; R H Lustig
Journal:  Int J Obes Relat Metab Disord       Date:  2003-02

2.  Serotonin improves glucose metabolism by Serotonylation of the small GTPase Rab4 in L6 skeletal muscle cells.

Authors:  Ramona Al-Zoairy; Michael T Pedrini; Mohammad Imran Khan; Julia Engl; Alexander Tschoner; Christoph Ebenbichler; Gerhard Gstraunthaler; Karin Salzmann; Rania Bakry; Andreas Niederwanger
Journal:  Diabetol Metab Syndr       Date:  2017-01-03       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.